Leukocyte Adhesion Deficiency II: Therapy and Genetic Defect
Leukocyte Adhesion Deficiency II: Therapy and Genetic Defect
复制标题
白细胞粘附缺陷 II:治疗和遗传缺陷
作者:
M. Wild;K. Lühn;T. Marquardt;D. Vestweber
Leukocyte adhesion deficiency II (LAD II) is a rare congenital disease which is caused by a defect in fucosylation of glycoconjugates. Hypofucosylated structures include ligands for the selectin family of adhesion molecules. This results in a leukocyte adhesion defect causing an immunodeficiency. In addition, LAD II patients show severe mental and growth retardations suggesting a role of fucose in development. Recently, a LAD II patient was treated with oral supplementation of fucose. This simple therapy restored selectin ligands and corrected the immunodeficiency. However, in another patient the treatment protocol had no effect indicating that the biochemical defect in the latter patient is somewhat different. The genetic defect in LAD II has now been located to a gene encoding a GDP-fucose transporter which gates GDP-fucose into the Golgi where fucose is transferred onto glycoconjugates. Point mutations have been detected in this gene in several LAD II patients, which inactivate the transporter function. Thus, LAD II represents the first developmental and immune defect that is based on a malfunctioning nucleotide sugar transporter.
登录
查看更多内容
影响因子:
20.3
作者:
Price,TH;Ochs,HD;Gershoni-Baruch,R;Harlan,JM;Etzioni,A
通讯作者:
Etzioni,A
DOI:
10.1172/jci13480
发表时间:
2001
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
Hirschberg,CB
通讯作者:
Hirschberg,CB
DOI:
10.1073/pnas.82.9.3045
发表时间:
1985
影响因子:
11.1
作者:
Yamamoto,M;Boyer,AM;Schwarting,GA
通讯作者:
Schwarting,GA
影响因子:
20.3
作者:
Marquardt, T;Lühn, K;Vestweber, D
通讯作者:
Vestweber, D